small-molecule mTOR complex 1/2 inhibitors (Intellikine)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Namesmall-molecule mTOR complex 1/2 inhibitors (Intellikine)

Drug Alias Namesmall-molecule mTORC1/mTORC2 inhibitors (Intellikine)small-molecule mTOR complex 1/2 inhibitors (Intellikine)small-molecule mTORC1/mTORC2 inhibitors (Intellikine)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionmTOR Complex 2 inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors

TargetsMammalian target of Rapamycin (mTORC1)mTOR Complex 2

Therapy Area/IndicationsPolycystic Kidney Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIntellikine LLC

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIntellikine LLC

Active IndicationsN/A

Inactive IndicationsPolycystic Kidney Diseases

Other Information

ATC CodeN/A